Table 2.
Variables | Fall-related self-efficacye | P | |
---|---|---|---|
Low (n=40) | High (n=41) | ||
Age, mean±SD | 63.8±10.2 | 63.1±11.7 | 0.789a |
Gender, n (%) | |||
Male | 15 (38.5) | 25 (61.0) | 0.044 |
Female | 24 (61.5) | 16 (39.0) | |
BMI (kg/m2), n (%) | |||
<18.5 | 11 (27.5) | 3 (7.3) | 0.019 |
≥18.5, <25 | 21 (52.5) | 33 (80.5) | |
≥25 | 8 (20.0) | 5 (12.2) | |
Employment status, n (%) | |||
Employed | 12 (30.8) | 18 (43.9) | 0.225 |
Unemployed | 27 (69.2) | 23 (56.1) | |
Marital status, n (%) | |||
Married | 32 (80.0) | 32 (78.0) | 0.829 |
Others | 8 (20.0) | 9 (22.0) | |
Number of household members, n (%) | |||
Two or more | 31 (79.5) | 35 (85.4) | 0.489 |
One only (alone) | 8 (20.5) | 6 (14.6) | |
Painc, n (%) | |||
No | 13 (32.5) | 24 (58.5) | 0.033 |
Mild | 16 (40.0) | 13 (31.7) | |
Moderate to severe | 11 (27.5) | 4 (9.8) | |
Fatiguec, n (%) | |||
No | 6 (15.4) | 11 (26.8) | 0.012 |
Mild | 13 (33.3) | 22 (53.7) | |
Moderate to severe | 20 (51.3) | 8 (19.5) | |
History of falls within the last month, n (%) | |||
Yes | 12 (30.0) | 5 (12.2) | 0.049 |
No | 28 (70.0) | 36 (87.8) | |
CIPNd, median (IQR) | 30 (15.5) | 15 (11) | <0.001b |
at-test, bMann-Whitney U test, and χ2 test, cNo: NRS 0, mild: NRS 1-3, moderate to severe: NRS ≥4, dCAS for CIPN in survivors of cancer scores, eFSE scale scores. BMI: Body mass index, CIPN: Chemotherapy-induced peripheral neuropathy, SD: Standard deviation, IQR: Interquartile range, CAS: Comprehensive assessment scale, FSE: Falling self-efficacy, NRS: Numeric rating scale. Missing data were excluded.